Table 3.
Response in pediatric patients with cGvHD among the included papers.
| Author | N. of pts | Sclerodermic features n. | OR skin % | Lung involvement n. | OR lung % | ORR % | CR % | PR % | NR % | TTR days |
|---|---|---|---|---|---|---|---|---|---|---|
| Gonzalez Vincent | 9 | 6 | 100 | 7 | 86 | 89 | 22 | 67 | 11 | NA |
| Schoettler | 4 | 2 | NA | 4 | 50 | 50 | 0 | 50 | 50 | 21 |
| Uygun | 16 | 8 | 75 | 7 | 71 | 71 | 6.5 | 75 | 18.5 | NA |
| Moiseev | 17 | NA | NA | NA | NA | 81 | 20 | 61 | 19 | 71 |
| Mozo | 12 | 8 | 100 | 10 | 90 | 91 | 8 | 84 | 8 | 60 |
| Yang | 36 | NA | NA | NA | NA | 81 | 28 | 53 | 14 | 68 |
| Wei | 1 | NA | NA | NA | NA | 78 | 25 | 53 | 22 | NA |
| Marcuzzi | 7 | NA | NA | NA | NA | 100 | 0 | 100 | 0 | NA |
| Wang | 16 | 7 | 100 | 3 | 67 | 69 | 12.5 | 56.5 | 31 | NA |
CR complete remission, N. number, NA not applicable, NR non response, OR overall response, ORR overall response rate, PR partial response, TTR time to response.